PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33046669-3	2020	Methods: We reviewed the clinical records of 6 patients with the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 1, awaiting heart transplantation, who were provided with temporary e-VAD from 2018 to 2019.	e-vad	220-225	myristoylated alanine rich protein kinase C substrate	Homo sapiens	133-142	
33046669-11	2020	Conclusion: e-VAD may reverse end-organ dysfunction and improve outcomes in INTERMACS I heart transplant patients.	e-vad	12-17	myristoylated alanine rich protein kinase C substrate	Homo sapiens	76-85